Search Results
Rucaparib May Improve PFS in Patients With Ovarian Cancer
Rucaparib boosts PFS in BRCA-mutated recurrent ovarian cancer
Precision Medicine for Ovarian Cancer (2021)
Dr. Ledermann on Response to Rucaparib in Recurrent Ovarian Cancer
The Clinical Activity of Rucaparib in Patients With Ovarian Cancer
Defining Rucaparib’s Value in Recurrent Ovarian Cancer
Rucaparib for Ovarian Cancer
ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients
Rucaparib: Clinical Activity in Relapsed Ovarian Cancer
Rucaparib for Recurrent Ovarian Cancer
Rucaparib maintenance for recurrent ovarian carcinoma
Rucaparib Explored for High-Risk Ovarian Cancer
